Advertisement

Topics

FDA rejects second Vernalis cough/cold treatment

03:49 EDT 7 Aug 2017 | PharmaTimes

The US Food and Drug Administration has rejected Vernalis’ cough cold treatment CCP-08, which is being developed by US partner Tris Pharma.

Original Article: FDA rejects second Vernalis cough/cold treatment

NEXT ARTICLE

More From BioPortfolio on "FDA rejects second Vernalis cough/cold treatment"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...